Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.392% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: CNC(=S)N(C1=NCC(c2ccc([N+](=O)[O-])cc2)S1)c1ccccc1
b: O=C(C1CCCN(Cc2nc(-c3ccc(Cl)cc3)no2)C1)N1CCOCC1
c: CCOc1cc(NC(=S)NCc2ccco2)c(OCC)cc1NC(=O)c1ccco1
d: COC(=O)c1sccc1NC(=S)N1CCN(c2ccccc2F)CC1
e: O=C(CCn1c(=O)oc2ccccc21)Nc1cccc(Cl)c1
Answer: b. O=C(C1CCCN(Cc2nc(-c3ccc(Cl)cc3)no2)C1)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(C1CCCN(Cc2nc(-c3ccc(Cl)cc3)no2)C1)N1CCOCC1
O=C(C1CCCN(Cc2nc(-c3ccc(Cl)cc3)no2)C1)N1CCOCC1
[1-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperidin-3-yl]-morpholin-4-ylmethanone